Dermatopathology Service at Mayo Clinic Laboratories
We are dedicated to the consultation service with a main focus on unusual cutaneous neoplastic diseases, as well as complex medical conditions involving skin.
Endocrine Pathology Service at Mayo Clinic Laboratories
Our endocrine pathology section is highly specialized and provides a valuable consultative service that is hard to find elsewhere.
Neuropathogy at Mayo Clinic Laboratories
Learn more about neuropathology at Mayo Clinic Laboratories, which provides expert second options across the spectrum of neurological disease.
New Tests Launched in May - Insights
In May 2017, Mayo Medical Laboratories announced eight brand new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
CPT codes and LOINC update: May 2022 - Insights
This list includes updates posted to mayocliniclabs.com during the month of May.
TPMT Testing in Treatment of Inflammatory Bowel Disease [Test in Focus] - Insights
Detection of individuals with low thiopurine methyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.
PDL1 Testing for Lung Cancer [A Test in Focus] - Insights
Audio Interview Testing When to Order Specimen Performance Immunotherapies have recently emerged as a therapeutic option for patients with non-small-cell
Autoimmune Axonal Evaluation [Test in Focus] - Insights
Divyanshu Dubey, M.B.B.S. gives an overview of this test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be...
Mayo Clinic's Discovery's Edge Highlights How New Tests Are Developed - Insights
Discovery's Edge, Mayo Clinic's research magazine, recently highlighted how new tests are developed in Mayo Clinic’s Neuroimmunology Laboratory.
New Blood Test to Help Determine Heart Disease Highlighted in European Heart Journal - Insights
European Heart Journal recently highlighted Mayo Clinic's new blood test that may predict cardiovascular events in patients with or without coronary artery disease.